Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Eur J Pharm Biopharm. 2014 Dec 13;89:271–279. doi: 10.1016/j.ejpb.2014.12.010

Figure 6.

Figure 6

Retinitis scores distribution within each treatment strategy. In each treatment category, the retinitis scores of the other two groups were statistically compared with HDP-CDV intervention group. Except for 5-week pretreatment in which retinitis scores was not significantly different between HDP-CDV and CDV interventions, all other intervention paradigms showed significantly lower retinitis scores from HDP-CDV groups.